Thought Leadership
Final Word: Advocating for Biosimilar Approval Standards under BPCI
September 1, 2011
Chad A. Landmon
BioPharm International

Axinn partner Chad Landmon's article, "Final Word: Advocating for Biosimilar Approval Standards under BPCI" was published by BioPharm International.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.